US Stock MarketDetailed Quotes

SBFM Sunshine Biopharma

Watchlist

2.1500
-0.1200-5.29%

Close Mar 11 16:00 ET

2.1500
0.00000.00%

Post 16:20 ET

5.82MMarket Cap-0.02P/E (TTM)

Sunshine Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sunshine Biopharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q4	-- / 12.500M	--
--	2024/Q3	8.435M / 11.800M	--
--	2024/Q2	9.303M / 9.000M	--
--	2024/Q1	7.541M / 7.000M	--
--	2023/Q4	7.680M / 6.100M	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q4-- / 12.500M--

--2024/Q38.435M / 11.800M--

--2024/Q29.303M / 9.000M--

--2024/Q17.541M / 7.000M--

--2023/Q47.680M / 6.100M--

Unlock Free Earnings Estimates

Open Account

Sunshine Biopharma Earnings Reports

8-K: SUNSHINE BIOPHARMA REPORTS 2024 THIRD QUARTER RESULTS: YEAR-TO-DATE REVENUES UP 54%

Nov 7, 2024 16:48 ET

10-Q: Q3 2024 Earnings Report

Nov 5, 2024 16:06 ET

10-Q/A: Quarterly report (Amendment)

Aug 20, 2024 16:09 ET

8-K: SUNSHINE BIOPHARMA REPORTS 2024 SECOND QUARTER RESULTS: SECOND QTR REVENUES UP 67%, YTD REVENUES UP 61%

Aug 19, 2024 16:09 ET